“Analisi Costo-Efficacia Di Amfotericina B Liposomiale (L-AmB) Versus Amfotericina B Complesso Lipidico (ABLC) Nel Trattamento Empirico Della Neutropenia Febbrile”. Farmeconomia. Health Economics and Therapeutic Pathways 6, no. 4 (December 15, 2005): 333–347. Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/851.